Shuttle Pharma Files 8-K: Routine Admin Update, Nasdaq Listing Confirmed
Ticker: SHPH · Form: 8-K · Filed: Jan 8, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Jan 8, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: administrative, regulatory-compliance, corporate-governance
TL;DR
**SHPH filed a routine 8-K, confirming its Nasdaq listing and regulatory compliance.**
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on January 8, 2024, to report an "Other Event" and "Financial Statements and Exhibits." This filing primarily serves to update its registration information with the SEC, confirming its status as a Delaware corporation with its common stock (trading symbol SHPH) registered on The Nasdaq Stock Market LLC. For investors, this filing is a routine administrative update, indicating the company is maintaining its regulatory compliance and listing status, which is important for liquidity and transparency.
Why It Matters
This filing is a standard administrative update, confirming Shuttle Pharmaceuticals' continued compliance with SEC regulations and its listing on Nasdaq, which is crucial for investor confidence and market access.
Risk Assessment
Risk Level: low — This 8-K is a routine administrative filing with no new material financial or operational information, posing minimal risk.
Analyst Insight
This filing is purely administrative and does not contain new material information to warrant immediate investment action. Investors should continue to monitor for filings that provide updates on clinical trials, financial performance, or strategic developments.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — the registrant filing the 8-K
- The Nasdaq Stock Market LLC (company) — the exchange where SHPH common stock is registered
- Delaware (company) — state of incorporation for Shuttle Pharmaceuticals Holdings, Inc.
- SHPH (company) — trading symbol for Shuttle Pharmaceuticals Holdings, Inc.
Forward-Looking Statements
- Shuttle Pharmaceuticals Holdings, Inc. will continue to maintain its listing on The Nasdaq Stock Market LLC. (Shuttle Pharmaceuticals Holdings, Inc.) — high confidence, target: 2025-01-08
FAQ
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was January 8, 2024.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
On which stock exchange is Shuttle Pharmaceuticals Holdings, Inc.'s common stock registered?
Shuttle Pharmaceuticals Holdings, Inc.'s common stock is registered on The Nasdaq Stock Market LLC.
What is the trading symbol for Shuttle Pharmaceuticals Holdings, Inc.'s common stock?
The trading symbol for Shuttle Pharmaceuticals Holdings, Inc.'s common stock is SHPH.
What is the state of incorporation for Shuttle Pharmaceuticals Holdings, Inc.?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in Delaware.
Filing Stats: 893 words · 4 min read · ~3 pages · Grade level 12.7 · Accepted 2024-01-08 09:05:10
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 13KB
- 0001493152-24-001668.txt ( ) — 229KB
- shph-20240108.xsd (EX-101.SCH) — 3KB
- shph-20240108_lab.xml (EX-101.LAB) — 33KB
- shph-20240108_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Date: January 8, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer